Fără conexiune la internet — se afișează versiunea salvată a paginii.

10x Genomics, Inc…

USUSD
← Către Filtru
US:TXGLSE:0A88

10x Genomics, Inc. (LSE:0A88) — Biotechnology: Laboratory Analytical Instruments. Numărul de burse pe care se tranzacționează acțiunile companiei: 2. Pe această pagină — preț și grafic, dividende, principalii deținători și istoricul numărului de acțiuni.

Despre Companie

Site Web
10xgenomics.com
Sector
Industrials · Biotechnology: Laboratory Analytical Instruments
Sediu Central
Pleasanton, United States
Director General
Serge Saxonov
Angajați
1 178
Fondată
2012
Acțiuni în Circulație
120.21 mil.
Free Float
118.19 mil.
Capitalizare de Piață
11.53 mld. USD
Insideri
1.46%
Investitori Instituționali
120.2%
Industrie (SIC)
Laboratory Analytical Instruments
Formă Juridică
XTIQ
ISIN
US88025U1097
LEI
5493003Z6741WNLG7H43
P/E
pierdere
FCF
121 mil. USD
Datorie
0 USD
numerar net
Câștiguri și FCF — pentru cele 12 luni până la 30.06.2026 (cel mai recent raport al companiei).
NAV
6.87 USD · P/NAV 12.9
Data Bilanțului30.06.2026
Active1.03 mld. USD
− Datorii205 mil. USD
= NAV (capital propriu al acționarilor companiei)826 mil. USD
− Fond Comercial6.92 mil. USD
− Imobilizări Necorporale61.2 mil. USD
= NAV Tangibil757 mil. USD
Acțiuni120 212 296
NAV pe Acțiune6.87 USD
NAV Tangibil pe Acțiune6.30 USD
Prețul Acțiunii (0A88)88.3100 USD
P/NAV12.86
Istoricul NAV
Data BilanțuluiNAVNAV pe Acțiune
30.06.2026826 mil. USD6.87 USD
31.03.2026814 mil. USD6.77 USD
31.12.2025796 mil. USD6.24 USD
30.09.2025785 mil. USD6.53 USD
30.06.2025773 mil. USD6.43 USD
31.03.2025707 mil. USD5.88 USD
31.12.2024710 mil. USD5.81 USD
30.09.2024723 mil. USD6.01 USD
Descriere

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

publicitate

Burse și Simboluri

BursăSimbolMonedăPrețTip
US USA StocksTXG principalăUSD75.59 +5.78%acțiuni ordinare
LSE London Stock Exchange0A88 IOBUSD88.31 +0.00%acțiuni ordinare

Preț pe 3 Luni

zi de creștere zi de scădereTreceți cu mouse-ul / atingeți o zi — prețurile de deschidere, închidere, maxim și minim

Cei Mai Mari Acționari

DeținătorParticipațieAcțiuniData Raportului
FMR, LLC14.67%17.63 mil.2026-06-30
Blackrock Inc.8.99%10.8 mil.2026-06-30
ARK Investment Managemen…8.32%10 mil.2026-06-30
Vanguard Portfolio Manag…5.81%6.98 mil.2026-06-30
Quantinno Capital Manage…4.55%5.47 mil.2026-06-30
Vanguard Capital Managem…4.23%5.08 mil.2026-06-30
Price (T.Rowe) Associate…3.78%4.54 mil.2026-06-30
Sumitomo Mitsui Trust Gr…3.49%4.19 mil.2026-06-30
Amova Asset Management A…3.49%4.19 mil.2026-06-30
VANGUARD INDEX FUNDS-Van…2.94%3.53 mil.2026-06-30
Morgan Stanley2.79%3.35 mil.2026-06-30
iShares Trust-iShares Ru…2.53%3.04 mil.2026-07-31
ARK ETF Trust-ARK Genomi…2.53%3.04 mil.2026-08-31
ARK ETF Trust-ARK Innova…2.5%3.01 mil.2026-08-31
VANGUARD INDEX FUNDS-Van…2.12%2.55 mil.2026-06-30
Fidelity Select PORT.s-S…1.66%2 mil.2026-07-31
Fidelity Rutland Square…1.37%1.65 mil.2026-07-31
Fidelity Select Portfoli…1.34%1.61 mil.2026-07-31
VANGUARD INDEX FUNDS-Van…1.22%1.47 mil.2026-06-30
T. Rowe Price New Horizo…1.21%1.46 mil.2026-06-30
SAXONOV SERGE WILSON (Ch…≈1.11%1.34 mil.2026-09-22
HINDSON BENJAMIN J (Pres…≈0.41%488 1822026-08-24
STUELPNAGEL JOHN R (Dire…≈0.27%328 4362026-09-03
TAICH ADAM (Chief Financ…≈0.26%316 3442026-09-09
MATEO ALAN V. (Director)≈0.07%85 8772026-06-04
KOSARAJU SRIDHAR (Direct…≈0.06%68 2782026-06-04
POPOVITS KIMBERLY J (Dir…≈0.03%37 4452026-06-04
TEICHMANN SARAH A. (Dire…≈0.02%28 0582026-08-14
SULIMAN SHEHNAAZ (Direct…≈0.02%23 7922026-09-22